Global Pharmaceutical 3PL Market Size study & Forecast, by Function (Domestic Transportation Management, International Transportation Management, and Value-added Warehousing and Distribution), Supply Chain (Cold Chain and Non-cold Chain), and Regional Ana

Global Pharmaceutical 3PL Market Size study & Forecast, by Function (Domestic Transportation Management, International Transportation Management, and Value-added Warehousing and Distribution), Supply Chain (Cold Chain and Non-cold Chain), and Regional Analysis, 2022-2029

Global Pharmaceutical 3PL Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. A Pharmaceutical 3PL refers to the efficient and safe delivery of pharmaceutical drug products to benefit patient health. It includes cold chain and non-cold chain supply chain. The Pharmaceutical 3PL market is expanding because of factors such as the rising pharmaceutical industry and growing demand from the healthcare sector.

According to Statista in 2021, the global pharma sector generates revenue of around USD 1.27 trillion in 2020. It includes production, development, and research activities. In 2022, the pharmaceutical market is anticipated to generate revenue of around USD 1,109.0 billion and expected to grow with CAGR of around 5.23 %. Whereas rising technological advancement services and growing R&D activities by market players are creating lucrative opportunities for the market. However, the threat of substitutes hampers the market growth in the forecast period.


The key regions considered for the Global Pharmaceutical 3PL Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising demand for biopharmaceutical third-party logistics, growing biologics and pharmaceutical drugs, and increasing import and export of pharmaceuticals, etc. Whereas the Asia Pacific is expected to grow with fastest growth rate with the highest CAGR owing to the rising technological advanced services and rising economic conditions

Major market player included in this report are:
DHL
FedEx
UPS
Kuehne + Nagel
DB Schenker
Nippon Express
Ceva Logistics
Kerry Logistics
Agility
XPO Logistics

Recent Developments in the Market:
 In February 2022: DHL Supply Chain (the global and North American contract logistics leader) announced a USD 400 million investment in its Life Sciences and Healthcare (LSHC) sector to increase its pharmaceutical and medical device distribution network footprint by 27%, with 3 million additional square feet. This investment includes the establishment of six new US locations by the end of 2022.
 January 2021: XPO Logistics Inc. has completed its previously announced acquisition of the majority of Kuehne + Nagel's contract logistics operations in the United Kingdom and Ireland, as part of its strategy to consolidate third-party logistics (3PL) services.

Global Pharmaceutical 3PL Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Function, Supply Chain, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:
By Function:
Domestic Transportation Management,
International Transportation Management,
Value-added Warehousing and Distribution

By Supply Chain:
Cold Chain
Non-cold Chain

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned

DHL
FedEx
UPS
Kuehne + Nagel
DB Schenker
Nippon Express
Ceva Logistics
Kerry Logistics
Agility
XPO Logistics

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.